Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Elisabeth, Bronder"'
Autor:
Edeltraut Garbe, Andreas Klimpel, Reinhold Kreutz, Antonios Douros, Elisabeth Bronder, Christiane Erley
Publikováno v:
Clinical Nephrology. 89:18-26
Objectives Drug-induced kidney injury (DIKI) may affect patients regardless of their baseline kidney function. Therefore, this study evaluated DIKI in patients with or without previous chronic kidney disease (CKD). Materials and methods Potential DIK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca90cd8338093582afb54762c4d622a
https://doi.org/10.5414/cn109212
https://doi.org/10.5414/cn109212
Autor:
Edeltraut Garbe, Matthias Huber, Andreas Klimpel, Frank Andersohn, Elisabeth Bronder, Antonios Douros, Juliane Bolbrinker, Oliver Meyer, Abdulgabar Salama, Reinhold Kreutz
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:1149-1155
Purpose Immune-mediated heparin-induced thrombocytopenia (HIT type II, HIT) is a potentially serious adverse drug reaction characterized by an increased risk of venous and arterial thrombosis. This study aimed to identify risk factors associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2de57d841e7c647dab9001ff2f90caf
https://doi.org/10.1002/pds.4235
https://doi.org/10.1002/pds.4235
Autor:
Edeltraut Garbe, Reinhold Kreutz, Andreas Klimpel, Thomas W. Flaig, Elisabeth Bronder, Antonios Douros
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 41:718-721
SummaryWhat is known and objective Tocilizumab (TCZ) is a humanized monoclonal antibody acting against the IL-6 receptor. It is a drug used in the treatment of rheumatoid arthritis and can be either given intravenously every 4 weeks or subcutaneously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f00f61602d0a0201b5ad42cc46552b7
https://doi.org/10.1111/jcpt.12456
https://doi.org/10.1111/jcpt.12456
Autor:
Elisabeth Bronder, Wolf-Dieter Ludwig, Bernd Mühlbauer, Ursula Gundert-Remy, Thomas Stammschulte
Publikováno v:
European Journal of Clinical Pharmacology. 71:1129-1138
In 1986, the risk of agranulocytosis prompted German authorities to restrict the indications for metamizole use. After an initial decline, prescriptions increased from20 million defined daily doses in 1990 to140 million in 2012. Concurrently, spontan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a613f26d4ebe4caaf6a0fa70328ddaa4
https://doi.org/10.1007/s00228-015-1895-y
https://doi.org/10.1007/s00228-015-1895-y
Autor:
Michael Thomae, Andreas Klimpel, Giselle Sarganas, Antonios Douros, Reinhold Kreutz, Edeltraut Garbe, Frank Andersohn, Elisabeth Bronder
Publikováno v:
British Journal of Clinical Pharmacology. 79:988-999
Aim Drug-induced liver injury (DILI) is often responsible for acute liver failure, drug withdrawal, boxed warnings or drug non-approval. Therefore, we conducted a case–control study to determine the hepatotoxic risk of a wide range of drugs. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5db55a433fa64126828b04d0fd1e531
https://doi.org/10.1111/bcp.12565
https://doi.org/10.1111/bcp.12565
Autor:
Andreas Klimpel, Edeltraut Garbe, Giselle Sarganas, Martin Huemer, Elisabeth Bronder, Wilhelm Haverkamp
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 35:e61-e65
Dronedarone is a promising, relatively new antiarrhythmic agent characterized by structural similarities to amiodarone but without amiodarone's severe organ toxicity. The proarrhythmic potential of dronedarone, however, is of increasing concern. We d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c895a9f31519875e0fb1183c52d68f13
https://doi.org/10.1002/phar.1573
https://doi.org/10.1002/phar.1573
Autor:
Reinhold Kreutz, Elisabeth Bronder, Christine Konzen, Matthias Huber, Andreas Klimpel, Frank Andersohn, Edeltraut Garbe, Michael Thomae, Giselle Sarganas
Publikováno v:
European Journal of Clinical Pharmacology. 71:219-227
Treatment with metamizole (dipyrone) has steadily increased in Germany over the last decade. The consequences of this increase for metamizole-induced agranulocytosis (MIA) are unclear. The present study addressed this topic using data from the Berlin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02daa8a68b7bd1db8d2c1e39c4f0e3b1
https://doi.org/10.1007/s00228-014-1777-8
https://doi.org/10.1007/s00228-014-1777-8
Autor:
Frank Andersohn, Edeltraut Garbe, Andreas Klimpel, Reinhold Kreutz, Antonios Douros, Michael Thomae, Elisabeth Bronder, Hans-Dieter Orzechowski
Publikováno v:
European Journal of Clinical Pharmacology. 70:453-459
The hepatotoxic potential of the analgesic flupirtine has attracted increased attention over the past years. Recently, risk minimisation measures such as maximum treatment duration of 2 weeks have been requested by the European Medicines Agency (EMA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69b6b6fdadbceeee971b5d0c03c0c3b
https://doi.org/10.1007/s00228-013-1631-4
https://doi.org/10.1007/s00228-013-1631-4
Autor:
Frank Andersohn, Andreas Grüneisen, Oliver Meyer, Reinhold Kreutz, Christine Konzen, Abdulgabar Salama, Martin Hildebrandt, Elisabeth Bronder, Ernst Späth-Schwalbe, Edeltraut Garbe, Matthias Huber, Andreas Klimpel, Michael Thomae, Hubert Schrezenmeier
Publikováno v:
European Journal of Clinical Pharmacology. 70:339-345
Drug-induced agranulocytosis (DIAG) is a rare but serious adverse drug reaction. The Berlin Case-Control Surveillance Study (FAKOS) aimed to identify pharmaceuticals with an increased risk for this condition.Adult patients with acute non-chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbb3b96898f050f6c8106802aa6fa615
https://doi.org/10.1007/s00228-013-1618-1
https://doi.org/10.1007/s00228-013-1618-1
Autor:
Elisabeth Bronder, Michael Thomae, Martin Hildebrandt, Hubert Schrezenmeier, Frank Andersohn, Oliver Meyer, Andreas Klimpel, Abdulgabar Salama, Andreas Grüneisen, Hanife Kurtal, Edeltraut Garbe, Ernst Späth-Schwalbe
Publikováno v:
European Journal of Clinical Pharmacology. 68:821-832
Drug-induced immune thrombocytopaenia is a rare, serious condition that can be triggered by numerous medications. To characterize the spectrum of drugs associated with immune thrombocytopaenia (ITP) in the Berlin Case–Control Surveillance Study (FA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0048ea216ab09f91c4086a234b4c592
https://doi.org/10.1007/s00228-011-1184-3
https://doi.org/10.1007/s00228-011-1184-3